Related Experiment Videos
Human recombinant interleukin-1 alpha is proinflammatory in normal human skin
P M Dowd1, R D Camp, M W Greaves
1Institute of Dermatology, United Medical School, St. Thomas' Hospital, London, UK.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|January 1, 1988
Summary
Recombinant human interleukin-1 alpha (HRIL-1 alpha) causes inflammation in human skin, leading to redness and swelling. This study confirms its potent proinflammatory effects in vivo.
Area of Science:
- Immunology
- Dermatology
- Cytokine research
Background:
- Interleukin-1 alpha (IL-1 alpha) is a key cytokine involved in inflammatory responses.
- Understanding the specific effects of recombinant human IL-1 alpha (HRIL-1 alpha) on human skin is crucial for its therapeutic and pathological implications.
Purpose of the Study:
- To determine the proinflammatory effects of HRIL-1 alpha in the skin of normal human volunteers.
- To characterize the dose-dependent inflammatory response induced by HRIL-1 alpha.
Main Methods:
- Intradermal injections of varying doses (10, 50, 100 U) of HRIL-1 alpha into human volunteers.
- Assessment of erythema and oedema at different time points (2 h to 48 h).
- Histological examination of skin biopsies to identify cellular infiltrates.
Main Results:
- HRIL-1 alpha induced a dose-related erythema and oedema in human skin.
- The inflammatory response peaked around 24 hours and persisted for up to 48 hours.
- Histology confirmed mononuclear cell infiltrates and neutrophil presence, indicating an acute inflammatory process. Heat-inactivated HRIL-1 alpha did not elicit these responses.
Conclusions:
- Recombinant human interleukin-1 alpha possesses potent proinflammatory properties when injected into human skin.
- HRIL-1 alpha elicits a significant and sustained inflammatory reaction characterized by erythema, oedema, and cellular infiltration.